Financhill
Sell
27

TOVX Quote, Financials, Valuation and Earnings

Last price:
$1.15
Seasonality move :
27.37%
Day range:
$1.14 - $1.19
52-week range:
$1.14 - $17.11
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.90x
P/B ratio:
0.13x
Volume:
48.5K
Avg. volume:
130.7K
1-year change:
-91.69%
Market cap:
$3.2M
Revenue:
--
EPS (TTM):
-$33.18

Earnings Data

Next earnings date for TOVX
Mar 25
2025
Most recent earnings per share
-$6.81
Missed by $1.56
(Nov 12/2024)
Consensus Estimate
-$5.25
(Nov 12/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TOVX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/25/2025 Q4 -- -- -- -$5.50 --
11/12/2024 Q3 -- -- -$6.81 -$5.25 -$1.56
08/13/2024 Q2 -- -- -$10.75 -- --
05/07/2024 Q1 -- -- -$7.50 -$8.50 $1.00
03/25/2024 Q4 -- -- -$8.12 -$8.25 $0.13
11/13/2023 Q3 -- -- -$4.85 -$8.50 $3.65
08/11/2023 Q2 -- -- -$8.50 -$8.50 --
05/16/2023 Q1 -- -- -$7.50 -$8.00 $0.50
03/16/2023 Q4 -- -- -$11.00 -$8.00 -$3.00
11/03/2022 Q3 -- -- -$7.50 -- --
08/11/2022 Q2 -- -- -$7.00 -- --
03/31/2022 Q1 -- -- -$7.75 -- --
12/31/2021 Q4 -- -- -$9.75 -- --
09/30/2021 Q3 -- -- -$6.25 -- --
06/30/2021 Q2 -- -- -$6.00 -- --
03/31/2021 Q1 -- -- -$32.50 -- --
12/31/2020 Q4 -- -- -$35.00 -- --
09/30/2020 Q3 -- -- -$35.00 -- --
06/30/2020 Q2 -- -- -$45.00 -- --
03/31/2020 Q1 -- -- -$50.00 -- --
12/31/2019 Q4 -- -- -$47.50 -- --
09/30/2019 Q3 -- -- -$77.50 -- --
06/30/2019 Q2 -- -- -$57.50 -- --
03/31/2019 Q1 -- -- -$62.50 -- --
12/31/2018 Q4 -- -- -$240.86 -- --
09/30/2018 Q3 -- -- -$232.50 -- --
06/30/2018 Q2 -- -- -$290.00 -- --
03/31/2018 Q1 -- -- -$162.50 -- --
12/31/2017 Q4 -- -- $192.50 -- --
09/30/2017 Q3 -- -- -$1,225.00 -- --
06/30/2017 Q2 -- -- -$262.50 -- --
03/31/2017 Q1 -- -- -$175.00 -- --
12/31/2016 Q4 -- -- -$177.37 -- --
09/30/2016 Q3 -- -- -$799.33 -- --
06/30/2016 Q2 -- -- -$875.01 -- --
03/31/2016 Q1 -- -- -$1,050.02 -- --
12/31/2015 Q4 -- -- -$1,058.00 -- --
09/30/2015 Q3 -- -- -$1,050.02 -- --
06/30/2015 Q2 -- -- -$1,662.52 -- --
03/31/2015 Q1 -- -- -$1,487.52 -- --
12/31/2014 Q4 -- -- -$787.51 -- --

Theriva Biologics Earnings Questions

  • How Much did Theriva Biologics Generate in Revenue Last Quarter?

    Theriva Biologics reported -- worth of top line sales in its most recent quarter.

  • Did Theriva Biologics Beat Earnings Last Quarter?

    Theriva Biologics announced earnings per share of -$6.81 which represents a miss of analyst forecast a -$5.25 per share.

  • Is Theriva Biologics Profitable?

    Theriva Biologics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Theriva Biologics EPS Next Year?

    Theriva Biologics's earnings are forecast to decrease from -$28.50 per share to -$28.75 per share next year representing a decrease of -16.67%.

  • When is Theriva Biologics's Earnings Date?

    Theriva Biologics's next earnings date is March 25, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock